Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P P Sfikakis

Showing results (1-10 of 104) with videos related to

Pageof 11
Sort By:
Annals of the Rheumatic Diseases|October 16, 2002
Behçet's disease: a new target for anti-tumour necrosis factor treatmentP P Sfikakis
Clinical Rheumatology|September 1, 1999
Adhesion and lymphocyte costimulatory molecules in systemic rheumatic diseasesP P Sfikakis, M Mavrikakis
Clinical and Experimental Rheumatology|November 1, 1995
Lymphocyte adhesion molecules in autoimmune rheumatic diseases: basic issues and clinical expectationsP P Sfikakis, G C Tsokos
Arthritis and Rheumatism|February 1, 1994
Increased levels of intercellular adhesion molecule 1 in patients with systemic lupus erythematosus: comment on the article by Mason et alP P Sfikakis, G C Tsokos
Clinical and Diagnostic Laboratory Immunology|May 1, 1997
Clinical use of the measurement of soluble cell adhesion molecules in patients with autoimmune rheumatic diseasesP P Sfikakis, G C Tsokos
Clinical Immunology and Immunopathology|June 1, 1997
Expression of CD28, CTLA4, CD80, and CD86 molecules in patients with autoimmune rheumatic diseases: implications for immunotherapyP P Sfikakis, C S Via
Lupus|December 28, 2014
Increased DNA double-strand breaks and enhanced apoptosis in patients with lupus nephritisV L Souliotis, P P Sfikakis
Clinical and Experimental Rheumatology|August 9, 2001
Glucocorticoid effects on myocardial performance in patients with systemic sclerosisL Antoniades, P P Sfikakis, M Mavrikakis
Clinical and Experimental Rheumatology|October 21, 2014
Do non-steroidal anti-inflammatory drugs increase or decrease cardiovascular risk in patients with rheumatoid arthritis?P P Sfikakis, V-K Bournia, G Kitas
Clinical Rheumatology|March 24, 1999
Circulating P- and L-selectin and T-lymphocyte activation and patients with autoimmune rheumatic diseasesP P Sfikakis, D Charalambopoulos, G Vaiopoulos, et al.
Pageof 11

Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Annals of the Rheumatic Diseases|October 16, 2002
Behçet's disease: a new target for anti-tumour necrosis factor treatmentP P Sfikakis
Clinical Rheumatology|September 1, 1999
Adhesion and lymphocyte costimulatory molecules in systemic rheumatic diseasesP P Sfikakis, M Mavrikakis
Clinical and Experimental Rheumatology|November 1, 1995
Lymphocyte adhesion molecules in autoimmune rheumatic diseases: basic issues and clinical expectationsP P Sfikakis, G C Tsokos
Arthritis and Rheumatism|February 1, 1994
Increased levels of intercellular adhesion molecule 1 in patients with systemic lupus erythematosus: comment on the article by Mason et alP P Sfikakis, G C Tsokos
Clinical and Diagnostic Laboratory Immunology|May 1, 1997
Clinical use of the measurement of soluble cell adhesion molecules in patients with autoimmune rheumatic diseasesP P Sfikakis, G C Tsokos
Clinical Immunology and Immunopathology|June 1, 1997
Expression of CD28, CTLA4, CD80, and CD86 molecules in patients with autoimmune rheumatic diseases: implications for immunotherapyP P Sfikakis, C S Via
Lupus|December 28, 2014
Increased DNA double-strand breaks and enhanced apoptosis in patients with lupus nephritisV L Souliotis, P P Sfikakis
Clinical and Experimental Rheumatology|August 9, 2001
Glucocorticoid effects on myocardial performance in patients with systemic sclerosisL Antoniades, P P Sfikakis, M Mavrikakis
Clinical and Experimental Rheumatology|October 21, 2014
Do non-steroidal anti-inflammatory drugs increase or decrease cardiovascular risk in patients with rheumatoid arthritis?P P Sfikakis, V-K Bournia, G Kitas
Clinical Rheumatology|March 24, 1999
Circulating P- and L-selectin and T-lymphocyte activation and patients with autoimmune rheumatic diseasesP P Sfikakis, D Charalambopoulos, G Vaiopoulos, et al.
Pageof 11